These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3994204)

  • 21. Cutaneous phaeohyphomycosis of the sole caused by Exophiala jeanselmei and its susceptibility to amphotericin B, 5-FC and ketoconazole.
    Hironaga M; Mochizuki T; Watanabe S
    Mycopathologia; 1982 Aug; 79(2):101-4. PubMed ID: 6290889
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm.
    Randhawa MA; Gondal MA; Al-Zahrani AH; Rashid SG; Ali A
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2015; 50(2):119-24. PubMed ID: 25560257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome.
    Paredes K; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J
    Rev Iberoam Micol; 2015; 32(1):34-9. PubMed ID: 24594291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A disc plate assay for characterization of the effect of interaction between polyenes and azoles on growth of Candida albicans CA12.
    Cao B; Tsang PW; Tsang DN; Samaranayake LP; Wang J
    Microbios; 1996; 87(352):161-7. PubMed ID: 9050253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.
    Cuenca-Estrella M; Mellado E; Díaz-Guerra TM; Monzón A; Rodríguez-Tudela JL
    J Antimicrob Chemother; 2000 Sep; 46(3):475-7. PubMed ID: 10980178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
    Batura-Gabryel H; Wieczorek U; Mlynarczyk W
    Pneumonol Alergol Pol; 1997; 65(5-6):355-9. PubMed ID: 9340063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal susceptibility of 50 Candida isolates from invasive mycoses in Chile.
    Silva V; Alvarado D; Diaz MC
    Med Mycol; 2004 Jun; 42(3):283-5. PubMed ID: 15283244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of resistance to amphotericin B during therapy for Candida glabrata infection in an immunocompetent host.
    Sterling TR; Gasser RA; Ziegler A
    Clin Infect Dis; 1996 Jul; 23(1):187-8. PubMed ID: 8816156
    [No Abstract]   [Full Text] [Related]  

  • 30. [Investigation of the activity of the preparation cerbiden against Candida spp].
    Hladun NP; Bondarenko AS; Nahorna SS; Smyrnova OV
    Mikrobiol Z; 2002; 64(6):57-61. PubMed ID: 12664551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug resistance in Candida albicans and Candida glabrata.
    Kerridge D; Fasoli M; Wayman FJ
    Ann N Y Acad Sci; 1988; 544():245-59. PubMed ID: 3063171
    [No Abstract]   [Full Text] [Related]  

  • 32. Imidazole and polyene activity against chloroquine-resistant Plasmodium falciparum.
    Pfaller MA; Krogstad DJ
    J Infect Dis; 1981 Oct; 144(4):372-5. PubMed ID: 6270216
    [No Abstract]   [Full Text] [Related]  

  • 33. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
    Linares MJ; Muñoz JF; Solís F; Rodríguez FC; Valero A; Casal M
    Rev Esp Quimioter; 1998 Mar; 11(1):64-9. PubMed ID: 9795292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel synergism of two antifungal agents, copiamycin and imidazole.
    Uno J; Shigematsu ML; Arai T
    Antimicrob Agents Chemother; 1983 Oct; 24(4):552-9. PubMed ID: 6316846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Killing kinetics of caspofungin, micafungin, and amphotericin B against Candida guilliermondii.
    Cantón E; Pemán J; Sastre M; Romero M; Espinel-Ingroff A
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2829-32. PubMed ID: 16870779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Resistance of fungi to antifungal antibiotics].
    Drouchet E
    Pathol Biol; 1967 Dec; 15(23):1222-6. PubMed ID: 4867327
    [No Abstract]   [Full Text] [Related]  

  • 37. Slime production and proteinase activity of Candida species isolated from blood samples and the comparison of these activities with minimum inhibitory concentration values of antifungal agents.
    Ozkan S; Kaynak F; Kalkanci A; Abbasoglu U; Kustimur S
    Mem Inst Oswaldo Cruz; 2005 May; 100(3):319-23. PubMed ID: 16113876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of amphotericin B against Candida lusitaniae clinical isolates.
    Prigitano A; Biraghi E; Pozzi C; Viviani MA; Tortorano AM
    J Chemother; 2010 Feb; 22(1):71-2. PubMed ID: 20227999
    [No Abstract]   [Full Text] [Related]  

  • 39. In-vitro antifungal activity of sertaconazole, bifonazole, ketoconazole, and miconazole against yeasts of the Candida genus.
    Carrilo-Muñoz AJ; Tur C; Torres J
    J Antimicrob Chemother; 1996 Apr; 37(4):815-9. PubMed ID: 8722548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amphotericin B-induced in vitro postantifungal effect on Candida species of oral origin.
    Ellepola AN
    Med Princ Pract; 2012; 21(5):442-6. PubMed ID: 22678101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.